Cargando…

Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis

Background and objectives: Brain-derived neurotrophic factor (BDNF) is one of the most studied neurotrophins. Low BDNF concentrations have been noted in patients with traditional cardiovascular disease risk factors and have been associated with the increased risk of stroke/transient ischemic attack...

Descripción completa

Detalles Bibliográficos
Autores principales: Karantali, Eleni, Kazis, Dimitrios, Papavasileiou, Vasileios, Prevezianou, Angeliki, Chatzikonstantinou, Symela, Petridis, Foivos, McKenna, Jack, Luca, Alina-Costina, Trus, Constantin, Ciobica, Alin, Mavroudis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004775/
https://www.ncbi.nlm.nih.gov/pubmed/33809965
http://dx.doi.org/10.3390/medicina57030297
_version_ 1783671980196626432
author Karantali, Eleni
Kazis, Dimitrios
Papavasileiou, Vasileios
Prevezianou, Angeliki
Chatzikonstantinou, Symela
Petridis, Foivos
McKenna, Jack
Luca, Alina-Costina
Trus, Constantin
Ciobica, Alin
Mavroudis, Ioannis
author_facet Karantali, Eleni
Kazis, Dimitrios
Papavasileiou, Vasileios
Prevezianou, Angeliki
Chatzikonstantinou, Symela
Petridis, Foivos
McKenna, Jack
Luca, Alina-Costina
Trus, Constantin
Ciobica, Alin
Mavroudis, Ioannis
author_sort Karantali, Eleni
collection PubMed
description Background and objectives: Brain-derived neurotrophic factor (BDNF) is one of the most studied neurotrophins. Low BDNF concentrations have been noted in patients with traditional cardiovascular disease risk factors and have been associated with the increased risk of stroke/transient ischemic attack (TIA). We aimed to study the correlation of BDNF serum levels with acute stroke severity and its potential role as a biomarker in predicting functional outcome. Materials and methods: We systematically searched PubMed, Web of Science, and the Cochrane database using specific keywords. The endpoints examined were the correlation of BDNF with functional outcome, the National Institute of Health stroke scale (NIHSS) measured at the acute phase, and stroke infarct volume. We also compared serum BDNF levels between stroke patients and healthy controls. Results: Twenty-six records were included from the initial 3088 identified. Twenty-five studies reported NIHSS and BDNF levels on the first day after acute stroke. Nine studies were further meta-analyzed. A statistically significant negative correlation between NIHSS and BDNF levels during the acute phase of stroke was noted (COR: −0.3013, 95%CI: (−0.4725; −0.1082), z = −3.01, p = 0.0026). We also noted that BDNF levels were significantly lower in patients with stroke compared to healthy individuals. Due to the heterogeneity of studies, we only conducted a qualitative analysis regarding serum BDNF and functional outcome, while no correlation between BDNF levels and stroke infarct volume was noted. Conclusions: We conclude that in the acute stroke phase, stroke severity is negatively correlated with BDNF levels. Concurrently, patients with acute stroke have significantly lower BDNF levels in serum compared to healthy controls. No correlations between BDNF and stroke infarct volume or functional outcome at follow-up were noted.
format Online
Article
Text
id pubmed-8004775
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80047752021-03-29 Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis Karantali, Eleni Kazis, Dimitrios Papavasileiou, Vasileios Prevezianou, Angeliki Chatzikonstantinou, Symela Petridis, Foivos McKenna, Jack Luca, Alina-Costina Trus, Constantin Ciobica, Alin Mavroudis, Ioannis Medicina (Kaunas) Review Background and objectives: Brain-derived neurotrophic factor (BDNF) is one of the most studied neurotrophins. Low BDNF concentrations have been noted in patients with traditional cardiovascular disease risk factors and have been associated with the increased risk of stroke/transient ischemic attack (TIA). We aimed to study the correlation of BDNF serum levels with acute stroke severity and its potential role as a biomarker in predicting functional outcome. Materials and methods: We systematically searched PubMed, Web of Science, and the Cochrane database using specific keywords. The endpoints examined were the correlation of BDNF with functional outcome, the National Institute of Health stroke scale (NIHSS) measured at the acute phase, and stroke infarct volume. We also compared serum BDNF levels between stroke patients and healthy controls. Results: Twenty-six records were included from the initial 3088 identified. Twenty-five studies reported NIHSS and BDNF levels on the first day after acute stroke. Nine studies were further meta-analyzed. A statistically significant negative correlation between NIHSS and BDNF levels during the acute phase of stroke was noted (COR: −0.3013, 95%CI: (−0.4725; −0.1082), z = −3.01, p = 0.0026). We also noted that BDNF levels were significantly lower in patients with stroke compared to healthy individuals. Due to the heterogeneity of studies, we only conducted a qualitative analysis regarding serum BDNF and functional outcome, while no correlation between BDNF levels and stroke infarct volume was noted. Conclusions: We conclude that in the acute stroke phase, stroke severity is negatively correlated with BDNF levels. Concurrently, patients with acute stroke have significantly lower BDNF levels in serum compared to healthy controls. No correlations between BDNF and stroke infarct volume or functional outcome at follow-up were noted. MDPI 2021-03-22 /pmc/articles/PMC8004775/ /pubmed/33809965 http://dx.doi.org/10.3390/medicina57030297 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Review
Karantali, Eleni
Kazis, Dimitrios
Papavasileiou, Vasileios
Prevezianou, Angeliki
Chatzikonstantinou, Symela
Petridis, Foivos
McKenna, Jack
Luca, Alina-Costina
Trus, Constantin
Ciobica, Alin
Mavroudis, Ioannis
Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title_full Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title_fullStr Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title_full_unstemmed Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title_short Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis
title_sort serum bdnf levels in acute stroke: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004775/
https://www.ncbi.nlm.nih.gov/pubmed/33809965
http://dx.doi.org/10.3390/medicina57030297
work_keys_str_mv AT karantalieleni serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT kazisdimitrios serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT papavasileiouvasileios serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT prevezianouangeliki serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT chatzikonstantinousymela serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT petridisfoivos serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT mckennajack serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT lucaalinacostina serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT trusconstantin serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT ciobicaalin serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis
AT mavroudisioannis serumbdnflevelsinacutestrokeasystematicreviewandmetaanalysis